GSK Crohn’s disease pill fails in Phase III
August 27, 2013Sales and Marketing GSK, vercirnon
A late-stage trial of GlaxoSmithKline’s investigational Crohn’s disease drug failed to benefit patients. The SHIELD-1 study was investigating vercirnon – …
Doctor questions FDA’s diet drug approvals
August 23, 2013Research and Development, Sales and Marketing BMJ, Belviq, EMA, FDA, Vivus, diet pills, obesity
Lilly drawn into China bribery scandal
August 22, 2013Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery, corruption, lilly, payments
Merck told to make $1 billion in cuts
August 22, 2013Sales and Marketing Leerink Swann, MSD, Merck, Odanacatib, sugammadex
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
